Characterization of myocardial function, structure, and metabolism across the spectrum of cardiac diseases using CMR and MRS – CMR Registry

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00040637

Enrollment

100000

Registered

2026-07-23

Start date

2025-04-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular diseases

Interventions

Group 1: • Cardiac magnetic resonance imaging (CMR) according to clinical indication •In defined subgroups: magnetic resonance spectroscopy (MRS), including proton MRS (¹H-MRS) and/or phosphorus MRS (

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: • ability to provide informed consent • Clinical indication for cardiac magnetic resonance imaging (CMR) • Ability to understand and comply with the instructions provided by the MRI staff

Exclusion criteria

Exclusion criteria: • Absence of written informed consent for study participation

Design outcomes

Primary

Measure	Time frame
The primary endpoint is the systematic collection and analysis of CMR-derived imaging parameters in patients with cardiovascular diseases and their association with clinical diagnoses and subsequent clinical outcomes	—

Secondary

Measure	Time frame
MRS-derived parameters (¹H-MRS and/or ³¹P-MRS), exercise CMR parameters obtained during MRI-compatible bicycle ergometry, and feasibility and image quality measures of the applied imaging techniques	—

Countries

Germany

Contacts

Public ContactLisa Dannenberg

Clinical Trial Unit

ctu@med.uni-duesseldorf.de+492118105187

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 10, 2026